Hypokinetic-rigid syndrome in children and inborn errors of metabolism

A García-Cazorla1, C Ortez, B Pérez-Dueñas

  • 1Department of Neurology, Hospital Sant Joan de Déu, Passeig Sant Joan de Deu 2, 08950 Esplugues, Barcelona, Spain.

Insights

Hypokinetic-rigid syndrome (HRS), or parkinsonism, is uncommon in children. This review guides pediatric neurologists in diagnosing and treating metabolic causes of HRS, highlighting specific genetic conditions and therapeutic approaches.

Area of Science:

  • Pediatric Neurology
  • Metabolic Disorders
  • Neurodegenerative Diseases

Background:

  • Hypokinetic-rigid syndrome (HRS), characterized by hypokinesia, bradykinesia, rigidity, and tremor, is rare in children.
  • Acquired causes include infections, encephalitis, hypoxia, and drugs; genetic causes primarily involve inborn errors of metabolism (IEM).
  • IEM-related HRS often presents with other neurological signs and may improve with targeted therapies.

Purpose of the Study:

  • To provide pediatric neurologists with a practical guide for the clinical approach to metabolic HRS.
  • To outline diagnostic procedures and treatment strategies for HRS in children.
  • To review genetic causes of both dopa-responsive and non-responsive HRS.

Main Methods:

  • Review of literature on pediatric hypokinetic-rigid syndrome.
  • Focus on inborn errors of metabolism as a significant cause of genetic HRS.
  • Discussion of clinical presentation, diagnostic workup, and therapeutic options.

Main Results:

  • Key metabolic diseases causing HRS include neurotransmitter defects, metal storage diseases, energy metabolism disorders, and lysosomal diseases.
  • Treatment varies, with l-dopa + carbidopa effective for neurotransmitter defects; other conditions like Wilson disease require different interventions.
  • Genetic factors are crucial, especially in juvenile parkinsonism, necessitating consideration of dopa-responsive and non-responsive conditions.

Conclusions:

  • Metabolic disorders are an important genetic cause of HRS in children.
  • Early diagnosis and specific treatments, such as l-dopa, can significantly impact outcomes.
  • A comprehensive approach considering various genetic conditions is essential for managing pediatric parkinsonism.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...